期刊文献+

最大标准摄取值诊断非小细胞肺癌纵隔淋巴结转移的最佳界值 被引量:11

Optimal threshold in diagnosing mediastinal lymph node metastasis of non-small cell lung cancer with maximum standardized uptake value
暂未订购
导出
摘要 目的探讨18F-FDG PET/CT最大标准摄取值(SUVmax)诊断非小细胞肺癌(NSCLC)纵隔淋巴结转移的最佳临界值。方法回顾性分析130例NSCLC初诊患者共337个纵隔淋巴结的术前PET/CT资料,以术后病理结果为对照,根据淋巴结SUVmax绘制SUVmax的ROC曲线,计算NSCLC纵隔淋巴结转移的最佳SUVmax诊断界值。结果 337个纵隔淋巴结中,病理确诊为转移性淋巴结129个(129/337,38.28%),无转移淋巴结208个(208/337,61.72%)。纵隔淋巴结SUVmaxROC曲线下面积为0.842。当SUVmax为4.5时Youden指数最大(0.605),准确率最高(81.6%)。结论 18F-FDGPET/CT诊断NSCLC纵隔淋巴结转移的最佳临界值SUVmax≥4.5较为合适。 Objective To explore the optimal threshold in diagnosing mediastinal lymph node metastasis of non-small cell lung cancer(NSCLC) with PET/CT maximum standardized uptake value(SUVmax).Methods A total of 337 mediastinal lymph nodes from 130 histologically proved NSCLC patients without any therapy underwent 18F-FDG PET/CT,and the data were retrospectively reviewed,taking postoperative pathologic results as gold standards.According to SUVmax of mediastinal lymph nodes,ROC curves were drawn out to determine the SUVmax critical value,then put forward the best diagnostic threshold in diagnosing mediastinal lymph nodes metastasis in NSCLC by PET/CT.Results Among 337 mediastinal lymph nodes,129(129/337,38.28%) lymph nodes were diagnosed malignant and 208(208/337,61.72%) were benign by pathological diagnosis.According to SUVmax,the area under ROC curve was 0.842.When SUVmax was 4.5,Youden index was maximum(0.605),and the accuracy was the highest(81.6%).Conclusion The best threshold of SUVmax ≥4.5 to distinguish benign and malignant mediastinal lymph node is relatively appropriate by 18F-FDG PET/CT for NSCLC.
出处 《中国医学影像技术》 CSCD 北大核心 2012年第5期916-920,共5页 Chinese Journal of Medical Imaging Technology
关键词 非小细胞肺 肿瘤转移 正电子发射型体层摄影术 体层摄影术 X线计算机 18F氟脱氧葡萄糖 Carcinoma non-small-cell lung Neoplasm metastasis Positron-emission tomography Tomography X-ray computed Fluorodeoxyglucose F18
  • 相关文献

参考文献9

  • 1Martin N,Flehinger BJ,Zaman MB,et al.Prospective study of445lung carcinomas with mediastimal lymph node metastases.Thorac Cardiovasc Surg,1980,80(3):390-399.
  • 2Glazer GM,Orringer MB,Gross BH,et al.The mediastinum innon-small cell lung cancer:CT-surgical correlation.AJR Am JRoentgenol,1984,142(6):1101-1105.
  • 3Scott WJ,Gobar LS,Terry JD,et al.Mediastinal lymph nodestaging of non-small-cell lung cancer:A prospective comparison ofcomputed tomography and positron emission tomography.J Tho-rac Cardiovasc Surg,1996,111(3):642-648.
  • 4Vansteenkiste JF,Stroobants SG,De Leyn PR,et al.Lymphnode staging in non-small-cell lung cancer with FDG-PET scan:Aprospective study on 690lymph node stations from 68patients.JClin Oncol,1998,16(6):2142-2149.
  • 5Bryrant AS,Cerfolio RJ,Klemm KM,et al.Maximum standarduptake value of mediastinal lymph nodes on intergrated FDGPET/CT predicts pathology in patients with non-small cell lungcancer.Ann Thorac Surg,2006,82(2):417-423.
  • 6Lee BE,Redwine J,Foster C,et al.Mediastinoscopy might notbe necessary in patients with non-small cell lung cancer with medi-astinal lymph nodes having a maximum standardized uptake valueof less than 5.3.J Thorac Cardiovasc Surg,2008,135(3):615-619.
  • 7Hellwig D,Graeter TP,Ukena D,et al.18F-FDG PET for medi-astinal staging of lung cancer:Which SUV threshold make sense?J Nucl Med,2007,48(11):1761-1766.
  • 8Kasai T,Mottoori K,Horikoshi T,et al.Dual-time point scan-ning of integrated FDG PET/CT for the evaluation of mediastinaland hilar lymph nodes in non-small cell lung cancer diagnosed asoperable by contrast-enhanced CT.European Journal of Radiolo-gy,2010,75(2):143-146.
  • 9Cerfolio RJ,Bryant AS.Ratio of the maximum standardized up-take value FDG-PET of the mediastinal(N2)lymph nodes to theprimary tumor may be a universal predictor of nodal malignancy inpatients with non-small-cell lung cancer.Ann Thorac Surg,2007,83(5):1826-1829.

同被引文献114

  • 1陈宁波,麦刚.PET/CT在结直肠癌临床中的应用[J].华西医学,2008,23(6):1506-1507. 被引量:1
  • 2杨爱民,邓惠兴,欧阳艳,冯新丽,王淑霞,胡国瑛.^(99)Tc^m-MIBISPECT/CT同机融合断层显像对肺癌及其转移淋巴结的诊断价值[J].医学影像学杂志,2004,14(10):809-811. 被引量:10
  • 3于丽娟,锻玉,梁秀艳,王欣.^(18)F-FDG PET/CT显像在肺癌诊断及探查转移灶中的价值[J].中国医学影像技术,2007,23(4):605-607. 被引量:23
  • 4Vansteenkiste JF, Stroobants SG, De l.eyn PR, et al. l.ymph node staging in non smalbcell lung cancer with FDG-PET scan: A prospective study on 690 lymph node stations from 68 patients. J Clin Oncol, 1998, 16(6):2142 -2149.
  • 5Prenzel KL, M,Snig SP, Sinning JM, et al. Lymph node size and metastatic infiltration in non-small cell lung cancer. Chest, 2003, 123(2) :463-467.
  • 6Birim O, Kappetein AP, Stijnen T, et al. Meta-analysis of posi- tron emission tomographic and computed tomographic imaging in detecting mediastinal lymph node metastases in nonsmall cell lung cancer. Ann ThoracSurg, 2005,79(1) :375-382.
  • 7Tasci E, Tezel C, Orki A, et al. The role of integrated positron emission tomography and computed tomography in the assessment of nodal spread in cases with non small cell lung cancer. Interact Cardiovasc Thorac Surg, 2010, 10 (2) : 200-203.
  • 8Conzalez-Stawinski GV, Lemaire A, Merchant F, et al. A com- parative analysis of positron emission tomography and mediasti- noscopy in staging non-small cell lung cancer. J Thorac Cardio vascSurg, 2003,126(6) :1900- 1905.
  • 9Shim SS, Lee KS, Kim BT, et al. Non-small cell lung cancer: Prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging. Radiology, 2005,236(3):1011 -1019.
  • 10Kim YK, Lee KS, Kim BT, et al. Mediastinal nodal staging of nonsmall cell lung cancer using integrated ^18F-FDG PET/CT in a tuberculosis-endemic country: Diagnostic efficacy in 674 patients. Cancer, 2007, 109(6) :1068 -1077.

引证文献11

二级引证文献100

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部